Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ullén

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Cell Biophysics|August 1, 1995
Syngeneic anti-idiotypic antibodies eliminate excess radiolabeled idiotypes at experimental radioimmunolocalizationA Ullén, K Riklund Ahlström, R Makiya, et al.
Investigational New Drugs|October 30, 2017
Combined treatment with pemetrexed and vinflunine in patients with metastatic urothelial cell carcinoma after prior platinum-containing chemotherapy - results of an exploratory phase I studyH Pappot, H von der Maase, A Ullén, et al.
Journal of Immunological Methods|June 14, 1995
In vivo and in vitro interactions between idiotypic and antiidiotypic monoclonal antibodies against placental alkaline phosphataseA Ullén, B Nilsson, K R Ahlström, et al.
Immunology|August 24, 1999
H-2Dd engagement of Ly49A leads directly to Ly49A phosphorylation and recruitment of SHP1M R Daws, M Eriksson, L Oberg, et al.
The International Journal of Biological Markers|April 14, 2000
A new specific method for measuring S-100B in serumT Stigbrand, L Nyberg, A Ullén, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 1999
Idiotypic-anti-idiotypic antibody interactions in experimental radioimmunotargetingP Sandström, A Johansson, A Ullén, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1996
Secondary antibodies as tools to improve tumor to non tumor ratio at radioimmunolocalisation and radioimmunotherapyA Ullén, K R Ahlström, S Heitala, et al.
Cancer Research|December 1, 1995
Use of anticytokeratin monoclonal anti-idiotypic antibodies to improve tumor:nontumor ratio in experimental radioimmunolocalizationA Ullén, P Sandström, K R Ahlström, et al.
Cancer Research|January 19, 1999
Epitope specificity of the monoclonal anticytokeratin antibody TS1A Johansson, P Sandström, A Ullén, et al.
Cancer|December 24, 1997
Experimental radioimmunotargeting combining nonlabeled, iodine-125-labeled, and anti-idiotypic anticytokeratin monoclonal antibodies: a dosimetric evaluationR Rossi Norrlund, A Ullén, P Sandström, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Cell Biophysics|August 1, 1995
Syngeneic anti-idiotypic antibodies eliminate excess radiolabeled idiotypes at experimental radioimmunolocalizationA Ullén, K Riklund Ahlström, R Makiya, et al.
Investigational New Drugs|October 30, 2017
Combined treatment with pemetrexed and vinflunine in patients with metastatic urothelial cell carcinoma after prior platinum-containing chemotherapy - results of an exploratory phase I studyH Pappot, H von der Maase, A Ullén, et al.
Journal of Immunological Methods|June 14, 1995
In vivo and in vitro interactions between idiotypic and antiidiotypic monoclonal antibodies against placental alkaline phosphataseA Ullén, B Nilsson, K R Ahlström, et al.
Immunology|August 24, 1999
H-2Dd engagement of Ly49A leads directly to Ly49A phosphorylation and recruitment of SHP1M R Daws, M Eriksson, L Oberg, et al.
The International Journal of Biological Markers|April 14, 2000
A new specific method for measuring S-100B in serumT Stigbrand, L Nyberg, A Ullén, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 1999
Idiotypic-anti-idiotypic antibody interactions in experimental radioimmunotargetingP Sandström, A Johansson, A Ullén, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1996
Secondary antibodies as tools to improve tumor to non tumor ratio at radioimmunolocalisation and radioimmunotherapyA Ullén, K R Ahlström, S Heitala, et al.
Cancer Research|December 1, 1995
Use of anticytokeratin monoclonal anti-idiotypic antibodies to improve tumor:nontumor ratio in experimental radioimmunolocalizationA Ullén, P Sandström, K R Ahlström, et al.
Cancer Research|January 19, 1999
Epitope specificity of the monoclonal anticytokeratin antibody TS1A Johansson, P Sandström, A Ullén, et al.
Cancer|December 24, 1997
Experimental radioimmunotargeting combining nonlabeled, iodine-125-labeled, and anti-idiotypic anticytokeratin monoclonal antibodies: a dosimetric evaluationR Rossi Norrlund, A Ullén, P Sandström, et al.
Pageof 2